The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy.

Saved in:
Bibliographic Details
Title: The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy.
Authors: Dehinsilu J; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom., Sergaki C; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom., Amos G; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom., Fontana V; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Pirmohamed M; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Source: Frontiers in microbiomes [Front Microbiomes] 2023 Mar 03; Vol. 2, pp. 1061193. Date of Electronic Publication: 2023 Mar 03 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 9918540080706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-4338 (Electronic) Linking ISSN: 28134338 NLM ISO Abbreviation: Front Microbiomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41853372
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dehinsilu+J%22">Dehinsilu J</searchLink>; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sergaki+C%22">Sergaki C</searchLink>; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Amos+G%22">Amos G</searchLink>; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fontana+V%22">Fontana V</searchLink>; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pirmohamed+M%22">Pirmohamed M</searchLink>; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918540080706676%22">Frontiers in microbiomes</searchLink> [Front Microbiomes] 2023 Mar 03; Vol. 2, pp. 1061193. <i>Date of Electronic Publication: </i>2023 Mar 03 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918540080706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2813-4338 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2228134338%22">28134338 </searchLink><i>NLM ISO Abbreviation: </i>Front Microbiomes <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41853372
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/frmbi.2023.1061193
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1061193
    Titles:
      – TitleFull: The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dehinsilu J
      – PersonEntity:
          Name:
            NameFull: Sergaki C
      – PersonEntity:
          Name:
            NameFull: Amos G
      – PersonEntity:
          Name:
            NameFull: Fontana V
      – PersonEntity:
          Name:
            NameFull: Pirmohamed M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2023 Mar 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2813-4338
          Numbering:
            – Type: volume
              Value: 2
          Titles:
            – TitleFull: Frontiers in microbiomes
              Type: main
ResultId 1